Clinical Trials Logo

Clinical Trial Summary

Acute compartment syndrome (ACS) after revascularization for acute limb ischemia is a potentially limb-threatening condition and requires urgent fasciotomy. Compression ultrasound (CU) is an established method for measuring intravenous pressure in superficial veins and, for example, can determine central venous pressure in critically ill patients. In cadaver studies, compression ultrasound has been proven to correlate with invasive intra compartmental pressure (ICP) measurements. This study aims to determine CU's added diagnostic value compared to ICP in detecting ACS after revascularisation.


Clinical Trial Description

Acute compartment syndrome (ACS) after revascularization for acute limb ischemia is a potentially limb-threatening condition and requires urgent fasciotomy. It occurs when the tissue pressure within a closed muscle compartment exceeds the perfusion pressure and results in muscle and nerve ischemia. If clinically suspected, intra- compartmental pressure (ICP) is measured by inserting a needle into the area of ACS, usually the anterior tibial muscle compartment, while an attached pressure monitor records the pressure. This invasive diagnostic method is widely used as a standard with a sensitivity of 94% and specificity of 98%. Compression ultrasound (CU) is an established method for measuring intravenous pressure in superficial veins and, for example, can determine central venous pressure in critically ill patients. An ultrasound translucent probe measures the pressure applied on the skin surface with the ultrasound transducer. In cadaver studies, compression ultrasound has been proven to correlate with invasive ICP measurements. The elasticity ratio (ER, compartment diameter with and without external pressure) validated in a recently published animal model has a sensitivity of 94.4% and a specificity of 88.9% to diagnose a compartment syndrome properly. The first results in six trauma patients showed that the ER less than 10,5% of the anterior tibial compartment had a sensitivity of 95,8% and a specificity of 87,5% to an appropriate diagnosis of ACS. Thus, this non-invasive, low-cost, and secure diagnostic technique has not been validated in patients with ACS after revascularisation for acute lower limb ischemia yet has the potential to discriminate clinically suspected ACS sensitively. This study aims to determine CU's added diagnostic value compared to ICP in detecting ACS after revascularisation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04806555
Study type Interventional
Source Kantonsspital Aarau
Contact Andrej Isaak, Dr.med.
Phone +4162 838 4568
Email andrej.isaak@ksa.ch
Status Recruiting
Phase N/A
Start date February 1, 2021
Completion date January 31, 2023

See also
  Status Clinical Trial Phase
Completed NCT04113954 - Detecting Compartment Syndrome Pain in the Presence of Regional Anesthesia in Healthy Volunteers Phase 1
Terminated NCT03922139 - Botox for the Treatment of Chronic Exertional Compartment Syndrome Phase 1/Phase 2
Terminated NCT05006417 - Botox for the Treatment of Recurrent Chronic Exertional Compartment Syndrome Phase 4
Enrolling by invitation NCT03359031 - Effects of Perioperative Patient Education Regarding Compartment Syndrome on Post-operative Opioid Consumption N/A
Completed NCT04442672 - Early Diagnosis of Compartment Syndrome by Multimodal Detection Technique N/A
Enrolling by invitation NCT03604029 - Evaluating the Diagnostic Performance of ACS Using NIRS in Traumatized Lower Extremities
Recruiting NCT05830721 - Continuous Compartment Pressure Monitoring for Compartment Syndrome in VA-ECMO Patients N/A
Recruiting NCT06050499 - Chemical Analysis of Limb Microfluidics
Not yet recruiting NCT06079255 - Ischemia Detection During Development of Acute Compartment Syndrome
Recruiting NCT05466539 - Chronic Exertional Compartment Syndrome (CECS) Treated With Abobotulinumtoxin A Phase 4